We’ve built our capabilities to become your outsourcing partner of choice.

Explore our journey so far…

Timeline

2017

micromass

micromass
2017

Cambridge BioMarketing

Cambridge Biomarketing
The acquisition of Cambridge BioMarketing, a US-based healthcare communications business, provides Ashfield with industry-leading expertise in the fast-growing area of orphan and rare disease drugs and adds further capabilities in patient-focused communications programmes.
2017

Vynamic

Vynamic
Headquartered in Philadelphia, Vynamic's primary service offerings include: brand strategy, planning and launch, advanced commercial operations capabilities, strategic transformation and integration, product design and implementation, change leadership and business intelligence and analytics.
2017

Sellxpert

Sellxpert
The acquisition further increases Ashfield's ability to recruit highly qualified employees. The deployment of sales personnel and the recruitment of specialists and executives in the healthcare sector is one of the company’s intensely sought after services.
2016

STEM Marketing

STEM Marketing
The acquisition significantly expands our service offering and capabilities in the commercial and clinical services market and complements Ashfield Healthcare Communications global offering.
2016

Pegasus

Pegasus
The addition of Pegasus strengthens our existing communications offering and broadens our capabilities in patient and consumer communications programmes, as well as corporate reputation and crisis management for our growing client base.
2014

Nyxeon

Nyxeon
Our third acquisition in a year, Nyxeon deepens our scientific PR capabilities.
2014

Galliard

Galliard
This scientific PR agency diversifies our impressive healthcare communications portfolio.
2014

KnowledgePoint 360

KnowledgePoint 360
With our largest acquisition to date, Ashfield becomes the market leader in healthcare communications.
2013

MCG

MCG
This Canadian multi-channel marketing organisation complements our Canadian CSO capability.
2013

Expansis

Expansis
This Spanish CSO deepened our commercial presence in Europe.
2012

Pharmexx

Pharmexx
Pharmexx added true international reach and depth to our CSO capability.
2012

Synopia Rx

Synopia Rx
This strong US market access business enabled us to diversify further our commercial offering.
2012

Drug Safety Alliance

Drug Safety Alliance
Pharmacovigilance complemented our scientific services and ever-growing family of specialisms.
2012

Watermeadow Medical

Watermeadow Medical
Watermeadow strengthened our global healthcare communications substantially in the UK and US.
2010

WorldEvents

WorldEvents
With WorldEvents, we became the no.1 provider in international healthcare meetings & events.
2010

InforMed

InforMed
Global healthcare communications and market research brought scientific depth to our services.
2008

Universal

Universal
Our meeting & events capability could now serve both the US and UK healthcare markets.
2008

Business Edge

Business Edge
Pharma leadership and sales training services strengthened our considerable CSO offering.
2007

Procon

Procon
Moving into new territory, Procon brought our values to the UK’s healthcare events market.
2007

Alliance

Alliance
Alliance’s first-class medical call centre capability now allowed us to enter the US market.
2005

In2Focus

In2Focus
With the addition of In2Focus, we became the UK’s No. 1 contract sales organisation.
2002

Ventiv Health

Ventiv Health
Welcoming Ventiv into our family further enhanced our UK contract sales (CSO) presence.
2000

Ashfield

Ashfield
With Ashfield we entered the UK contract sales market; the start of great things to come.